Can spironolactone cause insomnia, restlessness, or sexual dysfunction (decreased libido)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Spironolactone and Sexual/Sleep Side Effects

Spironolactone frequently causes decreased libido due to its potent anti-androgenic effects, but insomnia and restlessness are not recognized side effects of this medication. 1, 2

Decreased Libido: Well-Established Side Effect

Decreased libido is a frequent and dose-dependent side effect of spironolactone, particularly in men, caused by its anti-androgenic mechanism. 1

Mechanism of Action

  • Spironolactone potently inhibits testosterone and dihydrotestosterone binding to androgen receptors at target tissues 1, 3
  • The drug decreases testosterone production directly at the testicular level and may inhibit 5-alpha-reductase activity 1, 3
  • This dual mechanism—blocking both androgen synthesis and receptor binding—explains the high frequency of sexual side effects 3, 4

Clinical Frequency by Population

  • In men with cirrhosis and ascites, the British Society of Gastroenterology identifies decreased libido as one of the most frequent side effects, occurring alongside impotence and gynecomastia 1
  • In women treated for acne, decreased libido is acknowledged but less prominently featured than menstrual irregularities and breast tenderness 1, 5
  • In ophthalmology patients treated for central serous chorioretinopathy, decreased libido is listed among the most common side effects 1

Dose-Dependency

  • Sexual side effects are strongly dose-dependent, with substantially higher risk at doses ≥150 mg/day 1, 6
  • Gynecomastia incidence demonstrates this relationship: 52.2% at ≥150 mg/day versus only 6.9% at 50 mg/day 1, 6
  • Lower doses (75-100 mg daily) are as effective as higher doses (150-300 mg daily) for acne treatment but with substantially fewer sexual side effects 1, 5

Insomnia and Restlessness: Not Documented Side Effects

Insomnia and restlessness are not listed among the documented side effects of spironolactone in current guidelines. 2

Recognized Side Effects Instead Include:

  • Headache (>10% of patients) 2
  • Diarrhea (>10% of patients) 2
  • Fatigue (1-2% of patients)—note this is the opposite of restlessness 2
  • Menstrual disruption (15-30% in women, dose-dependent) 2
  • Breast tenderness (3-5%) 2
  • Dizziness (3-4%) 2
  • Nausea (2-4%) 2
  • Polyuria/diuresis (1-2%) 2

Clinical Pitfall to Avoid

  • If a patient reports insomnia or restlessness while taking spironolactone, investigate alternative causes rather than attributing these symptoms to the medication 2
  • Review concomitant medications that may cause these symptoms (e.g., stimulants, decongestants, other medications) 2

Management Strategies for Sexual Side Effects

When decreased libido occurs, consider dose reduction as the first-line strategy, as lower doses maintain efficacy while reducing anti-androgenic effects. 1, 5

Specific Approaches:

  • Start with the lowest effective dose (75-100 mg daily for acne; 50 mg daily for other indications when possible) 1, 5
  • Consider alternative aldosterone antagonists such as eplerenone, which has 3- to 10-fold reduced affinity for androgen and progesterone receptors, resulting in fewer sexual side effects 1, 7, 6
  • Potassium canrenoate may also produce fewer sexual side effects compared to spironolactone 1

Key Distinction Between Agents:

  • Eplerenone's selective mineralocorticoid receptor antagonism (lacking the 17-alpha-thioacetyl group present in spironolactone) substantially reduces the likelihood of endocrine side effects including loss of libido, menstrual irregularities, gynecomastia, and impotence 7

References

Guideline

Spironolactone-Associated Decreased Libido

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Spironolactone Side Effects and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Spironolactone and endocrine dysfunction.

Annals of internal medicine, 1976

Guideline

Spironolactone for Acne Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Antialdosterones: incidence and prevention of sexual side effects.

Journal of steroid biochemistry, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.